Julia C Chisholm Selected Research

2-methylcyclopentadienyl manganese tricarbonyl (MMT)

4/2011

Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julia C Chisholm Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 08/2005
13	Rhabdomyosarcoma 01/2023 - 04/2011
7	Neoplasm Metastasis (Metastasis) 05/2023 - 10/2012
7	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 04/2011
3	Infections 01/2021 - 02/2008
3	Malignant mesenchymal tumor 01/2020 - 04/2011
2	Disease Progression 01/2022 - 01/2018
2	Febrile Neutropenia 02/2012 - 10/2006
1	Pathologic Complete Response 12/2022
1	Cross Infection (Nosocomial Infection) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2020
1	Ascites 01/2019
1	Chickenpox 01/2019
1	Herpes Zoster 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Sepsis (Septicemia) 07/2014
1	Hepatoblastoma 10/2012
1	Choroid Plexus Carcinoma 05/2010
1	Vaccine-Preventable Diseases 02/2008
1	Fever (Fevers) 06/2007
1	Neutropenia 06/2007

Drug/Important Bio-Agent (IBA)

4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2022
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
1	Circulating Tumor DNAIBA 10/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	varicella-zoster immune globulin (VZIG)IBA 01/2019
1	penicillamine-glutathione mixed disulfideIBA 01/2019
1	BI 6727IBA 01/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	VemurafenibIBA 01/2018
1	Proto-Oncogene Proteins B-rafIBA 01/2018
1	CoagulaseIBA 07/2014
1	Docetaxel (Taxotere)FDA Link 10/2012
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 04/2011
1	VaccinesIBA 02/2008
1	Dactinomycin (Actinomycin)FDA LinkGeneric 08/2005

Therapy/Procedure

12	Therapeutics 01/2023 - 03/2007
11	Drug Therapy (Chemotherapy) 01/2023 - 10/2006
10	Radiotherapy 05/2023 - 04/2011
3	Investigational Therapies (Experimental Therapy) 01/2021 - 01/2018
2	Induction Chemotherapy 01/2018 - 12/2013
1	Hyperthermic Intraperitoneal Chemotherapy 01/2021
1	Time-to-Treatment 01/2021
1	Length of Stay 01/2021
1	Duration of Therapy 01/2021
1	Precision Medicine 11/2019
1	Central Venous Catheters 07/2014
1	Hematopoietic Stem Cell Transplantation 02/2008